International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for De novo drug design

De novo drug design


As per available reports about 43 Relevant Journals, 54 Conferences, 10 Workshops are presently dedicated exclusively to De novo drug design and about 76 articles are being published on De novo drug design.

Denovo drug Design is a technique used for designing novel, nonpeptide, bioactive, small-molecule ligands for macromolecular binding pockets. The approach targets complementarity to 3-dimensional binding site properties of the target protein the structure of which is known from X-ray or nuclear magnetic resonance(NMR) data. These binding site properties include shape, size, electrostatics and lipophilicity. This technique can also be used to design links between fragments of larger molecules from fragment docking or in a scaffold-replacement approach. Computer-assisted molecular design supports drug discovery by suggesting novel chemotypes and compound modifications for lead structure optimization.

Denovo drug Design is a technique used for designing novel, nonpeptide, bioactive, small-molecule ligands for macromolecular binding pockets. The approach targets complementarity to 3-dimensional binding site properties of the target protein the structure of which is known from X-ray or nuclear magnetic resonance(NMR) data. These binding site properties include shape, size, electrostatics and lipophilicity. This technique can also be used to design links between fragments of larger molecules from fragment docking or in a scaffold-replacement approach. Computer-assisted molecular design supports drug discovery by suggesting novel chemotypes and compound modifications for lead structure optimization. While the aspect of synthetic feasibility of the automatically designed compounds has been neglected for a long time, we are currently witnessing an increased interest in this topic. Here, we review state-of-the-art software for de novo drug design with a special emphasis on fragment-based techniques that generate drug like, synthetically accessible compounds. The importance of scoring functions that can be used to predict compound reactivity and potency is highlighted, and several promising solutions are discussed. Recent practical validation studies are presented that have already demonstrated that rule-based fragment assembly can result in novel synthesizable compounds with drug like properties and a desired biological activity. Programs such as LUDI, CLIX, CAVEAT, LeapFrog etc. are commonly employed for the purpose.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

MARKET ANALYSIS:

The global chemical industry is expected to grow from $4 trillion to $5.3 trillion by 2020. According to a 2011 report from Pike Research, Green Chemistry represents a market opportunity that will grow dramatically from $2.8 billion in 2011 to $98.5 billion by 2020. The same report also estimates that Green Chemistry is forecast to save industry $65.5 billion by 2020. a part of the $5.3 trillion US chemical industry.

National Symposiums and Workshops:

  • World Orphan Drug Congress, Apr 20-22 2016, Washington, DC, USA
  • G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery, Feb 21-25 2016, Keystone, USA
  • Drug Discovery & Case Study Focus on Malarial Kinases, July 18-22, 2016, Milano, Lombardy, Italy
  • 17th Annual Drug Discovery Summit, June 2016, Berlin, Germany.
  • 7th International Conference on Drug Discovery and Therapy, February 15th - 18th, 2016, Dubai, UAE
  • Adverse Drug Reactions, Drug Interactions and Pharmacovigilance Course, United Kingdom.
  • 2nd RSC-BMCS symposium on mastering medicinal chemistry, United Kingdom.
  • Pharmacodynamics, Biomarkers and Personalised Therapy, United Kingdom.
  • Drug Development, Pharmacokinetics and Imaging, United Kingdom.
  • Computational Advances in Drug Discovery, Switzerland.
  • Protein Structure and Drug Design ICM Workshop, USA.
  • Selectbio  Epigenetics in Drug Discovery, United Kingdom.

List of Best International Conferences:

  1. 3rd Green Chemistry Conference 
    September 19-21, 2016 Las Vegas, USA
  2. 2nd Drug Discovery and Designing Conference
    Oct 31-Nov 02, 2016 Istanbul, Turkey
  3. Pharma Marketing Conference
    November 17-19, 2016 Alicante, Spain
  4. 8th Pharmaceutics and Novel Drug Delivery Systems Conference
    March 07-09, 2016 Madrid, Spain
  5. 4th Pharma Congress
    June 13-15, 2016 Berlin, Germany
  6. 7th Annual Pharma Summit
    June 20-22, 2016 New Orleans, USA
  7. 5th Pharmacists Annual Meeting
    July 11-13, 2016 Brisbane, Australia
  8. Medicinal Chemistry and Computer Aided Drug Designing Conference
    December 01-03, 2016 Chicago, USA
  9. 6th Pharma Congress
    July 14-16, 2016 Kualalumpur, Malaysia
  10. Nanomedicine and Nanotechnology in Healthcare Conference 
    July 25-27, 2016 Bangkok, Thailand
  11. 8th Annual Genotoxic Impurities Conference
    10 June, 2015 and 11 June, 2015
  12. Structure Based Drug Design Conference
    21st – 24th February 2016 Carlsbad, San Diego. USA.
  13. Modern Phenotypic Drug Discovery: Defining the Path Forward (D1)
    April 2—6, 2016 Big Sky Resort, Big Sky, Montana, USA.
  14. 18th International Conference on Phenotypic Drug Discovery
    April 22 - 23, 2016 London, United Kingdom
  15. 7th International Conference on Drug Discovery and Therapy
    February 15th - 18th, 2016 Dubai, UAE
  16. Pharmacokinetics for Pharmaceutical Scientists Course
    29 February – 4 March 2016 San Francisco, United States
  17. Pharmacodynamics, Biomarkers and Personalised Therapy
    29 February – 4 March 2016 Oxford, United Kingdom
  18. 16th World Congress of Anaesthesiologists
    28 August – 2 September 2016 Hong Kong, Hong Kong
  19. International Conference on Pharmacovigilance, Drug Safety and Risk Management
    Jul 20-21, 2015 Paris
  20. International Conference on Pharmaceutical Regulatory Affairs
    Aug 13-14, 2015 Venice
  21. International Conference on Pharmacovigilance and Clinical Trials
    Jul 20-21, 2015 Paris

Societies related:

  • FDA
  • Drug Watch
  • ORPHANET
  • Parenteral Drug Association
  • PharmGKB
  • US Food and Drug Administration (FDA)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Pharmaceutical Scientists (AAPS)
  • Clinical Trials Information from National Institutes for Health (NIH)
  • National Institute of Standards and Technology (NIST)

Related Companies:

  • Aptuit Pharmaceuticals
  • ERT Pharmaceuticals
  • SIRO Clinpharm Pvt. Ltd. Pharmaceuticals
  • ArisGlobal Computer Software
  • AAIPharma Services Corp. Pharmaceuticals
  • Celerion Pharmaceuticals

This page will be updated regularly.

This page was last updated on March 28, 2024

Conference Series Destinations